8h agoThe FlyBULLISH 74Analyst
Archived explainer. For the current picture see today's PLSE page.
Why Is PULSE BIOSCIENCES IN (PLSE) Stock Down Today?
By the Top Tier Newswire AI Desk · October 13, 2026 at 10:46 AM ET · reviewed against 4 wire stories
PULSE BIOSCIENCES IN (PLSE) is down -6.16% in the latest session. Our newswire has captured 4 stories on PLSE across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Pulse Biosciences (PLSE) shares fell 6.16% to close at $49.22. The decline occurred despite recent positive analyst revisions, with the stock trading well below its session high of $53.21.
What Happened
Oppenheimer raised its price target for Pulse Biosciences to $60 from $35, citing competitor issues. Mizuho also increased its price target to $55 from $45. Canaccord Genuity maintained a Buy rating and raised its price target to $58. The company announced the completion of enrollment in its pivotal atrial fibrillation study of the nPulse catheter, finishing three months ahead of schedule. Additionally, Pulse Biosciences disclosed inducement stock option grants for two new employees totaling 5,700 shares with an exercise price of $49.98, issued under Nasdaq Listing Rule 5635(c)(4).
What The Data Shows
The stock opened at $52.40 and hit a session high of $53.21 at 9:35 AM ET before sliding to a low of $49.22 at 10:40 AM ET. Volume was 0.0M shares, which is 0.1x the 3-month daily average. The company has a market capitalization of $3.8B and is unprofitable with a trailing twelve-month EPS of -1.18. The beta is 1.57, and the 52-week range is $12.56 to $58.90. Over the last 8 sessions, the stock moved 2.8% from $51.03 to $52.45. Recent insider activity includes two buys by COO Liane Rae Teplitsky totaling $200K, with no sells in the last 90 days. The stock printed one fresh 52-week high and 16 fresh 52-week lows on October 13, 2026.
What To Watch
Analysts continue to monitor the company's progress in its pivotal study and the impact of competitor dynamics on its valuation.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PLSE by the numbers
Last: $49.22Session: -6.16%7 sessions: +2.77%Coverage: 4 stories / 3 sourcesAI sentiment: 63/100 (bullish)Mkt cap: $3.8B52w: $12.56 to $58.90
The headlines behind the move
8h agoThe FlyBULLISH 64Analyst
Pulse Biosciences price target raised to $55 from $45 at Mizuho
9h agoInvesting.com Analyst RatingsBULLISH 64Analyst
Oppenheimer raises Pulse Biosciences price target on competitor issues
Oppenheimer raises Pulse Biosciences price target on competitor issues
1d agoMarketChameleonNEUTRAL 50General
PLSE discloses inducement grants for 5,700 shares with a $49.98 exercise price October 12, 2026
Pulse Biosciences (PLSE) reported inducement stock option grants to two new employees totaling up to 5,700 shares, issued October 8, 2026 under Nasdaq Listing Rule 5635(c)(4). The options carry a $49.98 exercise price (equal to the October 8 closing price) and vest over four years, with 1/4 vesting annually subject to continued employment.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on PLSE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier PLSE move explainers: 2026-10-13 · 2026-09-17 · 2026-09-16 · 2026-09-10 · 2026-09-09